Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.110
-0.120 (-2.84%)
At close: Apr 17, 2026, 4:00 PM EDT
4.058
-0.052 (-1.27%)
After-hours: Apr 17, 2026, 7:41 PM EDT
Whitehawk Therapeutics Revenue
In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.
Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
27.15
Revenue / Employee
$310,652
Employees
23
Market Cap
193.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.15M | -18.84M | -72.50% |
| Dec 31, 2024 | 25.98M | 1.63M | 6.69% |
| Dec 31, 2023 | 24.35M | 9.14M | 60.06% |
| Dec 31, 2022 | 15.22M | 14.10M | 1,258.57% |
| Dec 31, 2021 | 1.12M | -13.46M | -92.32% |
| Dec 31, 2020 | 14.58M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 20.16M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionWHWK News
- 2 days ago - Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series - PRNewsWire
- 8 days ago - Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 - PRNewsWire
- 4 weeks ago - Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PRNewsWire
- 5 weeks ago - Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 7 weeks ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 3 months ago - Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - PRNewsWire
- 4 months ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire